Megadosing Vitamin C Pushes Excess Ascorbate Down an Unwanted Oxalate Pathway

The Modern Fascination with Mega-Dose Ascorbic Acid

Walk into any pharmacy, supermarket, or wellness retailer, and you will find entire shelves dedicated to high-potency vitamin C. Brightly colored tubes of effervescent tablets promise rapid immune defense, foil packets boast one thousand milligrams of crystalline ascorbic acid in every single-serving drink mix, and wellness clinics market intravenous infusions delivering ten to fifty grams directly into the bloodstream. During seasonal transitions or at the first sign of fatigue, many consumers dissolve large doses of vitamin C in water, assuming higher intakes provide greater immune defense.

This cultural phenomenon has deep historical roots. In the 1970s, two-time Nobel laureate Linus Pauling captured global attention by advocating daily doses of vitamin C ranging from two to ten grams, arguing that such supraphysiological amounts could eliminate the common cold and protect against chronic degenerative diseases. Although subsequent clinical trials failed to support Pauling's sweeping claims, the belief that megadosing vitamin C is an innocent health habit remains widespread. The prevailing popular assumption remains simple: because vitamin C is a water-soluble micronutrient, any quantity that the human body does not immediately utilize will harmlessly wash out in the urine.

Human biochemistry, however, does not operate as an open, consequence-free drain. Every milligram of an ingested supplement must navigate saturable intestinal transport systems, engage with intracellular recycling mechanisms, pass through hepatic enzymatic pathways, and undergo filtration and reabsorption in the microscopic tubules of the kidneys. The Recommended Dietary Intake (RDI) for vitamin C set by health authorities, including the New Zealand Ministry of Health and Australia's National Health and Medical Research Council, is forty-five milligrams per day for healthy adults, with eighty-five to one hundred and ten milligrams recommended during pregnancy and lactation. Even dietary standards established in North America and Europe target seventy-five to ninety milligrams daily for non-smoking adults, an amount designed to ensure near-complete tissue saturation while preventing scurvy and supporting collagen hydroxylation.

When an individual consumes one thousand or two thousand milligrams in a single burst, they deliver ten to twenty times the physiological daily requirement to their digestive tract. While the body adapts to fluctuating nutrient intakes, persistent megadosing exposes a serious toxicological bottleneck. When cellular transport mechanisms saturate and intracellular recycling enzymes are overwhelmed, excess circulating ascorbate is diverted down an irreversible oxidative catabolic pathway. The final, inescapable destination of that pathway is oxalic acid, an insoluble organic acid that combines with urinary calcium to construct the most common, agonizing kidney stones known to clinical medicine.

Saturable Intestinal Transport and the Bioavailability Cliff

Understanding how high-dose supplementation backfires begins with intestinal transport. Ascorbic acid cannot passively diffuse across cell membranes in unlimited amounts; its uptake relies on an active, carrier-mediated system known as Sodium-Dependent Vitamin C Transporter 1 (SVCT1).

Expressed predominantly on the apical brush border membrane of enterocytes lining the duodenum and jejunum, SVCT1 transports ascorbic acid against an electrochemical gradient by coupling its movement with the inward flow of two sodium ions. This transporter operates under classic Michaelis-Menten saturation kinetics. When dietary intake is modest, between thirty and one hundred milligrams, SVCT1 operates with high efficiency, absorbing seventy to ninety percent of available vitamin C.

As single doses increase above two hundred milligrams, however, SVCT1 transporters rapidly approach their maximal transport velocity. Pharmacokinetic research conducted at the United States National Institutes of Health by Dr. Mark Levine and colleagues demonstrated that steady-state plasma concentrations of ascorbic acid follow a steep sigmoidal curve. At a daily intake of one hundred milligrams, plasma concentrations reach approximately eighty percent of their biological maximum. Increasing intake to two hundred milligrams achieves near-complete cellular and plasma saturation, elevating resting plasma concentrations to between sixty and seventy micromoles per liter.

Beyond this threshold, fractional bioavailability falls off a cliff:

• At a single dose of two hundred milligrams, fractional intestinal absorption remains high, averaging between seventy-five and eighty percent.
• At a single dose of five hundred milligrams, fractional absorption drops noticeably, with approximately fifty percent of the ingested dose absorbed.
• At a single dose of one thousand milligrams (one gram), absorption efficiency plummets below forty-five percent.
• At single doses of two thousand milligrams or more, fractional absorption crashes under twenty-five percent, leaving the overwhelming majority of the active ingredient unabsorbed in the intestinal lumen.

This steep drop in absorption creates two physiological issues. First, unabsorbed ascorbic acid draws water into the intestinal lumen via osmosis, accelerating transit and triggering the cramping and loose stools that clinical nutritionists call bowel tolerance.

Second, the absorbed fraction enters a vascular system whose carrying capacity is already full. In the proximal renal tubules, the sodium-dependent transporter SVCT2 reabsorbs filtered ascorbate back into blood up to a plasma threshold of sixty to seventy micromoles per liter. Above this saturation level, reabsorption ceases and excess ascorbate spills directly into the urinary filtrate.

The Metabolic Cascade from Ascorbate to 2,3-Diketogulonate

The biological hazards of excess vitamin C are not confined to the passive urinary spillage of the parent molecule. The deeper problem lies in the oxidative catabolism that occurs within cells and tissues when circulating ascorbate concentrations exceed the capacity of physiological recycling systems.

In human physiology, ascorbic acid functions primarily as a single-electron reducing agent. By donating an electron to reactive oxygen species, lipid peroxides, or enzyme-bound metal ions such as iron and copper, ascorbate protects cellular membranes and facilitates critical enzymatic reactions. When an ascorbate molecule donates its first electron, it converts into the monodehydroascorbate radical. If a second electron is transferred, the molecule becomes dehydroascorbic acid (DHA), the fully oxidized form of vitamin C.

Under normal physiological conditions, dehydroascorbic acid is not discarded. Human cells possess energy-dependent salvage pathways designed to conserve antioxidant reserves. Within the cytosol of red blood cells, hepatocytes, and renal cells, specialized enzymes—primarily dehydroascorbic acid reductase (DHAR) and glutaredoxin, powered by reduced glutathione (GSH) and NADPH—rapidly reduce DHA back into active ascorbic acid. This redox cycle allows a single molecule of vitamin C to be utilized repeatedly, neutralizing cellular stress and subsequently returning to its active state without requiring immediate replacement from dietary sources.

However, dehydroascorbic acid is chemically unstable in an aqueous environment at neutral pH and mammalian body temperature (37 degrees Celsius). The heterocyclic lactone ring of DHA is susceptible to spontaneous nucleophilic attack by water molecules. When an individual ingests megadoses of vitamin C, the surge of incoming ascorbate dramatically accelerates intracellular generation of DHA. When the concentration of DHA exceeds the catalytic capacity of dehydroascorbic acid reductase and cellular glutathione pools, excess DHA cannot be recycled.

Instead, the unstable dehydroascorbic acid molecule undergoes irreversible ring-opening hydrolysis. The lactone ring cleaves, permanently converting DHA into 2,3-diketogulonic acid (2,3-DKG). This reaction represents the decisive point of no return in vitamin C metabolism. Once 2,3-diketogulonic acid forms, no known biological pathway in the human body can reconstruct ascorbic acid. The vitamin identity of the molecule is permanently lost, and the carbon backbone enters an obligate degradation pathway that generates toxic fragments.

The Irreversible Cleavage Pathway to Oxalic Acid

The emergence of 2,3-diketogulonic acid initiates a sequence of fragmentation steps that yield low-molecular-weight organic acids. The six-carbon backbone of 2,3-DKG is cleaved between carbon-2 and carbon-3, dividing the original vitamin C molecule into two distinct pieces:

• A four-carbon (C4) fragment, which hydrolyzes into benign metabolites such as L-threonic acid, L-threose, or L-xylosone. These four-carbon derivatives are easily filtered by the glomeruli and eliminated in the urine without posing known toxicological hazards to mammalian tissues.
• A two-carbon (C2) fragment, which undergoes oxidation to yield oxalic acid, commonly referred to in its ionized state as oxalate.

Alternatively, a portion of 2,3-diketogulonate can transform via glycolaldehyde and glycolate into glyoxylate, an intermediate subsequently converted into oxalate by the hepatic enzyme lactate dehydrogenase (LDH). Regardless of whether cleavage occurs via direct chemical hydrolysis or through glyoxylate intermediates, the net outcome remains identical: the terminal two carbons of excess ascorbic acid are converted directly into oxalic acid.

Herein lies one of the most critical evolutionary vulnerabilities in human metabolic biology: humans possess zero endogenous enzymes capable of degrading, metabolizing, or dismantling oxalic acid. Unlike specialized soil bacteria that express oxalate decarboxylase or oxalate oxidase, the human genome contains no genetic code for oxalate catabolism. In the human body, oxalate is a dead-end metabolic waste product.

Because mammalian cells cannot break down oxalate, every molecule of oxalate produced endogenously from the breakdown of excess vitamin C, as well as every molecule absorbed from high-oxalate foods like spinach and rhubarb, must be excreted from the body. The primary pathway of disposal is renal elimination. Oxalate molecules travel through systemic circulation to the kidneys, where they undergo unrestricted filtration through the renal glomeruli and are additionally secreted into the tubular lumen by specific organic anion transporters in the proximal tubules.

In a person with balanced nutrition, daily urinary oxalate excretion averages between twenty and forty milligrams per twenty-four hours, derived from endogenous amino acid turnover (primarily glycine and hydroxyproline breakdown) and dietary oxalate absorption. When high-dose vitamin C supplements flood the system, continuous cleavage of 2,3-diketogulonate drives endogenous oxalate production skyward, causing urinary oxalate concentrations to surge far beyond baseline physiological levels.

Renal Microlithiasis and Calcium Oxalate Crystallization

Once oxalate enters tubular fluid, it encounters conditions that foster stone formation (nephrolithiasis). As the loop of Henle and collecting ducts reabsorb water to maintain fluid balance, luminal solutes become progressively concentrated.

As luminal water decreases, the concentration of dissolved ions rises. The two most critical ions in this microenvironment are free divalent calcium ($Ca^{2+}$) and divalent oxalate ($C_2O_4^{2-}$). Calcium is filtered in massive quantities by the kidneys every day, and while more than ninety-eight percent is reabsorbed under the regulation of parathyroid hormone and vitamin D, a physiological concentration of free calcium remains in tubular fluid.

When dissolved calcium and dissolved oxalate meet in an aqueous medium, they exhibit an exceptionally high chemical affinity for one another. The thermodynamic solubility product constant ($K_{sp}$) of calcium oxalate is vanishingly small, approximately $2 \times 10^{-9}\text{ mol}^2/\text{L}^2$ at body temperature. When the mathematical product of free calcium and oxalate ion concentrations exceeds this solubility threshold, the solution transitions from an undersaturated state to a supersaturated state.

In physical chemistry, supersaturation is an unstable condition. When urinary oxalate concentrations cross the upper limit of metastability—a threshold known as the formation product—crystal nucleation occurs:

1. Nucleation: Individual calcium and oxalate ions collide and bind, organizing into microscopic crystal lattice nuclei.
2. Aggregation and Growth: Newly formed crystal seeds collide with neighboring ions and one another, coalescing into larger, clustered structures. Calcium oxalate crystallizes into two distinct mineral forms: calcium oxalate monohydrate (whewellite), which forms sharp, dense crystals with high tissue-binding affinity, and calcium oxalate dihydrate (weddellite), which forms bipyramidal, envelope-shaped crystals.
3. Epithelial Adhesion: In a healthy, diluted urinary stream, microscopic crystals are harmlessly flushed out. However, when urinary oxalate levels are abnormally high, sharp crystal faces cause microscopic trauma and oxidative injury to tubular epithelial membranes. This damage exposes basement membrane proteins, including phosphatidylserine and hyaluronic acid, to which calcium oxalate crystals bind with high affinity.
4. Formation of Randall's Plaques: Adherent crystals anchor to the renal papillary surface or accumulate in the subepithelial basement membrane of the thin limbs of the loop of Henle, serving as a nidus. Layer upon layer of organic matrix, calcium, and oxalate deposit onto this anchored nidus over months or years, ultimately growing into a macroscopic calculus capable of obstructing the renal calyx or ureter.

Calcium oxalate stones account for roughly eighty percent of all diagnosed kidney calculi. The sharp pain of renal colic occurs when a dislodged stone wedges in the ureter, obstructing urine flow and generating acute back-pressure in the kidney.

Vitamin C supplements significantly increase urinary oxalate excretion in both stone formers and nonstone formers, which may contribute directly to stone formation. — Journal of Endourology Meta-Analysis

This sequence of events highlights why urinary oxalate is universally recognized by nephrologists as an exceptionally potent lithogenic factor. While doubling urinary calcium increases calcium oxalate supersaturation linearly, small incremental increases in urinary oxalate concentrations exert a far greater mathematical impact on the supersaturation curve, tipping normal tubular fluid into rapid crystallization.

The Clinical Evidence: From Interventional Trials to Large Cohorts

The biochemical reality that vitamin C catabolizes into oxalate has been known to laboratory researchers for decades. For many years, however, commentators questioned whether in vitro experiments translated to living humans under real-world conditions. Critics suggested that measured increases in urinary oxalate were merely laboratory artifacts caused by spontaneous conversion of unabsorbed ascorbate into oxalate inside collection containers.

Modern clinical methods using immediate acid preservation and mass spectrometry have resolved this debate, demonstrating that urinary oxalate surges in vivo following high-dose supplementation across interventional trials and large cohorts.

In July 2026, researchers published a systematic review and meta-analysis in the Journal of Endourology (PMID: 42535313) that directly evaluated this clinical relationship. The investigators analyzed all interventional clinical trials published between 1965 and 2023 that examined the impact of vitamin C supplements on twenty-four-hour urinary stone risk parameters, specifically urinary oxalate, citrate, and calcium.

The findings were unequivocal:

• Across nine included interventional clinical trials, pooled analysis revealed a statistically significant mean increase in twenty-four-hour urinary oxalate excretion of +9.72 milligrams per day following vitamin C supplementation compared to baseline values (p < 0.001).
• When compared directly against placebo control groups, vitamin C supplementation produced a statistically significant mean increase of +6.45 milligrams of urinary oxalate per twenty-four hours (p < 0.001).
• Subgroup analyses demonstrated that this surge in urinary oxalate occurred across the board: it was statistically significant in established stone formers and in non-stone formers alike (p < 0.05 for all comparisons).
• Crucially, the meta-analysis revealed that high-dose vitamin C supplementation produced zero beneficial changes in urinary citrate (a natural crystal inhibitor) or urinary calcium excretion. The entire physiological impact was tilted toward increased lithogenic risk.

An increase of nearly ten milligrams of urinary oxalate per day represents a twenty-five to forty percent leap above normal baseline twenty-four-hour excretion. In individuals whose baseline urinary concentration is already approaching the limits of calcium oxalate metastability, an extra ten milligrams is more than enough to cross the crystallization threshold.

These interventional findings are corroborated by long-term epidemiological studies tracking health outcomes over decades. The Health Professionals Follow-Up Study followed forty-five thousand two hundred and fifty-one men who had no history of kidney stones at baseline over a fourteen-year window. After controlling for fluid intake, dietary calcium, potassium, magnesium, animal protein, and sodium, researchers found that men in the highest category of total vitamin C intake (one thousand milligrams or more per day) had a forty-one percent higher relative risk of developing a kidney stone compared to men consuming less than ninety milligrams daily (relative risk: 1.41; 95% confidence interval: 1.11 to 1.80).

When researchers isolated the source of the nutrient, they observed that elevated risk was driven by supplemental vitamin C, rather than dietary vitamin C obtained from whole foods. A parallel analysis within the Physicians' Health Study and the Swedish Mammography Cohort and Cohort of Swedish Men published in JAMA Internal Medicine confirmed these conclusions. In the Swedish study, which tracked over twenty-three thousand men for eleven years, men who reported taking regular high-dose vitamin C supplements exhibited nearly double the incidence of kidney stones compared to non-supplement users (adjusted hazard ratio: 1.92).

Beyond common kidney stones, chronic megadosing can precipitate severe nephrological damage: secondary hyperoxaluria leading to acute renal oxalosis. A case report published in the Journal of Medical Case Reports (PMC11924107) documented secondary hyperoxaluria and acute tubular injury in a patient consuming one to two grams of daily effervescent vitamin C supplements. Extensive deposition of calcium oxalate crystals within renal tubules induced acute renal failure, resolving only after cessation of the supplement and aggressive hydration therapy.

Food-First Ascorbate: Why the Natural Matrix Protects the Kidneys

Given the physiological risks associated with isolated high-dose supplements, a fundamental question emerges: why does dietary vitamin C consumed from whole, intact foods not trigger the same surge in urinary oxalate and kidney stone risk?

The answer lies in the profound differences between an isolated chemical megadose and the nutrient-dense food matrix created by botanical evolution. When an individual consumes vitamin C through whole dietary plants, the delivery profile changes completely:

1. Modest, Non-Saturating Doses: Whole foods deliver vitamin C in quantities that work in harmony with the transport kinetics of SVCT1. A medium-sized orange delivers seventy milligrams of vitamin C; a cup of fresh strawberries supplies eighty-five milligrams; and a standard green kiwifruit provides eighty-five to ninety milligrams (with gold kiwifruit varieties delivering upwards of one hundred and fifty milligrams). These amounts fall within the sweet spot of maximal intestinal absorption efficiency (seventy to ninety percent), ensuring steady cellular uptake without overwhelming systemic clearance thresholds.
2. Slow Gastric Release: Unlike effervescent tablets that release hundreds of milligrams of free ascorbate in minutes, food-bound vitamin C is held within plant cell walls. Dietary fiber slows gastric emptying and transit, releasing ascorbate gradually to match transporter capacity.
3. Potassium and Citrate Protection: Citrus, berries, and kiwifruit deliver potassium citrate alongside vitamin C. Hepatic metabolism converts citrate into bicarbonate, raising urinary pH. In the tubules, citrate binds free ionic calcium to form soluble calcium citrate, lowering the free calcium pool available to precipitate with oxalate.
4. Intrinsic Hydration: Fresh whole fruits and vegetables consist of eighty to ninety percent intracellular water. Consuming vitamin C through food inherently delivers accompanying hydration, expanding urinary volume and keeping concentrations of calcium and oxalate below the metastability threshold.

For residents of New Zealand and surrounding regions, this food-first reality is particularly relevant. New Zealand is renowned for its production of fresh kiwifruit (Actinidia deliciosa and Actinidia chinensis), blackcurrants (Ribes nigrum), and brassicas. Consuming two fresh kiwifruits per day delivers between one hundred and seventy and three hundred milligrams of natural vitamin C, accompanied by five grams of prebiotic dietary fiber, significant potassium, and zero excess oxalate risk. Human feeding trials have confirmed that eating two kiwifruits daily achieves complete plasma and leukocyte vitamin C saturation within four weeks, providing all the theoretical immune and antioxidant benefits that consumers seek from supplements, entirely free of renal lithogenic stress.

Navigating Doses, Supplement Panels, and Daily Routines

For many consumers, the appeal of supplements lies in convenience. While achieving optimal vitamin C status through a diverse, whole-food diet is the gold standard of clinical nutrition, supplemental forms remain widely used. If an individual chooses to use a dietary supplement to fill a verified dietary shortfall, navigating product labels and understanding ingredient formats is vital for preserving kidney health.

When inspecting product packaging, consumers encounter several distinct chemical formulations, each accompanied by specific marketing claims:

• Standard Ascorbic Acid: The most widely available form, consisting of purified, crystalline L-ascorbic acid. While chemically identical to the vitamin C found in nature, standard ascorbic acid has an acidic pH (approximately 2.5 when dissolved in water). Consuming massive doses on an empty stomach can cause mild gastric irritation in sensitive individuals.
• Mineral Ascorbates (Buffered Vitamin C): Formulations using calcium, sodium, or magnesium ascorbate reduce acidity, easing stomach tolerance for those with reflux. However, buffering does not change metabolism. Once in circulation, the ascorbate molecule dissociates and enters the same catabolic pathway to 2,3-DKG and oxalate. High-dose calcium ascorbate also delivers extra calcium into the renal filtrate alongside oxalate precursors.
• Liposomal Vitamin C: Phospholipid encapsulation may facilitate enterocyte uptake and reduce gastrointestinal irritation. However, bypassing SVCT1 does not alter renal clearance. Absorbed ascorbate exceeding tissue demand still undergoes hepatic oxidation to 2,3-DKG and renal oxalate clearance.
• "Immune Complex" Powders and Effervescents: Popular single-serving drink powders and fizzy tablets frequently bundle one thousand milligrams of ascorbic acid with zinc, elderberry extract, and artificial sweeteners. Because they taste like pleasant fruit-flavored beverages, consumers often drink several glasses a day during winter illness, unwittingly delivering two to three thousand milligrams of ascorbic acid into their kidneys day after day.

To maintain optimal wellness while rigorously safeguarding renal function, clinical nutritionists recommend adhering to three foundational principles:

1. Calibrate Dosing to Physiological Reality: Recognize that the human body cannot utilize more than two hundred to two hundred and fifty milligrams of supplemental vitamin C per day. Daily supplements providing one hundred to two hundred and fifty milligrams provide necessary enzymatic support while ensuring fractional absorption remains high and urinary oxalate spillage remains negligible.
2. Divide Doses Rather Than Taking Single Megadoses: If a healthcare professional advises an intake higher than two hundred milligrams for a specific reason, divide the daily total into smaller portions taken with meals throughout the day. Splitting a four-hundred-milligram total into two two-hundred-milligram doses reduces peak plasma spikes and limits SVCT1 saturation compared to ingesting the entire quantity in a single morning tablet.
3. Prioritize Daily Hydration: Water is the ultimate antidote to kidney stone formation. Maintaining an abundant, pale urinary output (targeting two to two and a half liters of fluid per day) dilutes calcium and oxalate ions, ensuring that even when minor metabolic fluctuations occur, the urinary environment remains safely below the crystallization threshold.

Medical Boundaries, Risk Groups, and When to Seek Guidance

A responsible, science-backed approach to human wellness requires drawing unambiguous boundaries between general nutritional education and clinical medicine. Dietary supplements, including vitamin C, are nutritional tools designed to support normal biological function; they are not pharmaceuticals and cannot diagnose, treat, cure, mitigate, or prevent any disease, including urolithiasis, renal dysfunction, or systemic infections.

While a modest, food-first vitamin C intake is safe and universally essential for all human beings, there are specific clinical populations for whom high-dose vitamin C supplementation is strictly contraindicated or presents serious physiological hazards:

• Personal or Family History of Kidney Stones: Individuals with prior calcium oxalate stones or affected first-degree relatives should avoid high-dose vitamin C. In stone formers, baseline urinary oxalate is often elevated and natural crystal inhibitors can be impaired, making an additional five to ten milligrams of urinary oxalate a direct trigger for recurrence.
• Chronic Kidney Disease: Impaired renal filtration delays oxalate excretion. Excess ascorbate catabolism can cause systemic hyperoxalemia, precipitating calcium oxalate in the kidney tissue, heart, and joints.
• Primary or Secondary Hyperoxaluria: Inherited glyoxylate enzyme defects (Primary Hyperoxaluria) cause severe endogenous oxalate production, which supplemental ascorbate worsens. Similarly, malabsorptive conditions (Crohn's, celiac, gastric bypass) increase enteric oxalate absorption, ruling out supplemental precursors.
• Patients with Hereditary Hemochromatosis or Iron Overload: Vitamin C upregulates intestinal absorption of non-heme dietary iron by reducing ferric iron ($Fe^{3+}$) to the more soluble ferrous state ($Fe^{2+}$). In individuals carrying genetic mutations for hemochromatosis, chronic high-dose vitamin C consumption worsens systemic iron deposition, accelerating oxidative tissue damage in the liver, pancreas, and heart.
• Individuals with Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency: G6PD is an erythrocyte enzyme essential for regenerating NADPH and maintaining reduced glutathione. In individuals with G6PD deficiency, massive doses of vitamin C can trigger oxidative hemolysis of red blood cells.
• Special Physiological Populations: Pregnancy and lactation represent unique life stages where nutrient demands are elevated, but pharmacological megadoses are inappropriate. The New Zealand Ministry of Health and obstetric guidelines recommend meeting elevated demand (eighty-five to one hundred milligrams daily) through a colorful diet of fruits and vegetables, warning against self-prescribed high-dose tablets. Similarly, parents should never administer adult-strength vitamin C effervescents or megadose powders to infants or children under eighteen years of age; pediatric kidneys are smaller, fluid volumes are lower, and children easily meet their dietary requirements through ordinary family meals.

The ultimate takeaway is one of physiological proportion. Vitamin C remains an indispensable cornerstone of human nutrition, powering collagen synthesis, maintaining vascular integrity, assisting neurotransmitter production, and defending cells against oxidative stress. Yet the human body is an exquisitely balanced biological system, not an industrial vessel that can be flooded without consequence. By setting aside the marketing myths of the mega-dose, respecting the biological limits of intestinal transporters, and sourcing ascorbic acid primarily from the vibrant, protective matrix of whole foods, wellness consumers can enjoy robust, lifelong health while keeping their kidneys clear and stone-free.

This article is for general education and does not replace advice from a qualified healthcare professional.

Sources

pubmed.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov

ods.od.nih.gov

www.kidney.org

pubmed.ncbi.nlm.nih.gov

www.nrv.gov.au

This article is for general education and does not replace advice from a qualified healthcare professional.